Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Pariente

Showing results (21-30 of 220) with videos related to

Pageof 22
Sort By:
Pharmacoepidemiology and Drug Safety|July 29, 2017
Adherence with direct oral anticoagulants in nonvalvular atrial fibrillation new users and associated factors: a French nationwide cohort studyGéric Maura, Antoine Pariente, François Alla, et al.
Drug Safety|April 12, 2023
Drug-Drug Interactions and the Risk of Emergency Hospitalizations: A Nationwide Population-Based StudyLouis Létinier, Julien Bezin, Ana Jarne, et al.
Expert Opinion on Drug Safety|February 19, 2015
Is there really a link between benzodiazepine use and the risk of dementia?Sophie Billioti de Gage, Antoine Pariente, Bernard Bégaud
Patient Education and Counseling|April 15, 2019
What we know about media communication on antibiotics and antimicrobial resistance: A systematic review of the scientific literatureDaniel Catalán-Matamoros, Antoine Pariente, Carlos Elías-Pérez
Diabetes Research and Clinical Practice|March 13, 2018
Impact of cancer diagnosis on persistence of oral antidiabetic drugsLouis Létinier, Yohann Mansiaux, Antoine Pariente, et al.
British Journal of Clinical Pharmacology|August 4, 2018
Reply to 'The easy misuse of antidepressants during pregnancy is depressing'Anne Bénard-Laribière, Anne-Laure Sutter-Dallay, Antoine Pariente
Drug Safety|November 5, 2023
Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in FranceSibylle de Germay, Allison Singier, Francesco Salvo, et al.
The American Journal of Medicine|August 12, 2019
The ReplyJulien Bezin, Nicholas Moore, Philippe Gabriel Steg, et al.
Drug Safety|May 8, 2024
Can We Ask ChatGPT About Drug Safety? Appropriateness of ChatGPT Responses to Questions About Drug Use and Adverse Reactions Received by Pharmacovigilance CentersAntoine Pariente, Francesco Salvo, Virginie Bres, et al.
Diabetes Care|May 15, 2023
Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390Julien Bezin, Clément Mathieu, Jean-Luc Faillie, et al.
Pageof 22

Showing results (21-30 of 220) with videos related to

Sort By:
Pageof 22
Pharmacoepidemiology and Drug Safety|July 29, 2017
Adherence with direct oral anticoagulants in nonvalvular atrial fibrillation new users and associated factors: a French nationwide cohort studyGéric Maura, Antoine Pariente, François Alla, et al.
Drug Safety|April 12, 2023
Drug-Drug Interactions and the Risk of Emergency Hospitalizations: A Nationwide Population-Based StudyLouis Létinier, Julien Bezin, Ana Jarne, et al.
Expert Opinion on Drug Safety|February 19, 2015
Is there really a link between benzodiazepine use and the risk of dementia?Sophie Billioti de Gage, Antoine Pariente, Bernard Bégaud
Patient Education and Counseling|April 15, 2019
What we know about media communication on antibiotics and antimicrobial resistance: A systematic review of the scientific literatureDaniel Catalán-Matamoros, Antoine Pariente, Carlos Elías-Pérez
Diabetes Research and Clinical Practice|March 13, 2018
Impact of cancer diagnosis on persistence of oral antidiabetic drugsLouis Létinier, Yohann Mansiaux, Antoine Pariente, et al.
British Journal of Clinical Pharmacology|August 4, 2018
Reply to 'The easy misuse of antidepressants during pregnancy is depressing'Anne Bénard-Laribière, Anne-Laure Sutter-Dallay, Antoine Pariente
Drug Safety|November 5, 2023
Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in FranceSibylle de Germay, Allison Singier, Francesco Salvo, et al.
The American Journal of Medicine|August 12, 2019
The ReplyJulien Bezin, Nicholas Moore, Philippe Gabriel Steg, et al.
Drug Safety|May 8, 2024
Can We Ask ChatGPT About Drug Safety? Appropriateness of ChatGPT Responses to Questions About Drug Use and Adverse Reactions Received by Pharmacovigilance CentersAntoine Pariente, Francesco Salvo, Virginie Bres, et al.
Diabetes Care|May 15, 2023
Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390Julien Bezin, Clément Mathieu, Jean-Luc Faillie, et al.
Pageof 22